Cancer incidence in the AGRICAN cohort study (2005-2011). by Lemarchand, C et al.
Lemarchand, C; Tual, S; Levque-Morlais, N; Perrier, S; Belot, A; Vel-
ten, M; Guizard, AV; Marcotullio, E; Monnereau, A; Clin, B; Baldi, I;
Lebailly, P; AGRICAN group, (2017) Cancer incidence in the AGRI-
CAN cohort study (2005-2011). Cancer epidemiology, 49. pp. 175-
185. ISSN 1877-7821 DOI: https://doi.org/10.1016/j.canep.2017.06.003
Downloaded from: http://researchonline.lshtm.ac.uk/4398243/
DOI: 10.1016/j.canep.2017.06.003
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
1 
 
Cancer incidence in the AGRICAN cohort study (2005-2011) 1 
 2 
Authors: Clémentine Lemarchanda,b,c, Séverine Tuala,b,c, Noémie Levêque-Morlaisa,b,c, 3 
Stéphanie Perriera,b,c, Aurélien Belotd, Michel Veltene, Anne-Valérie Guizarda,f, Elisabeth 4 
Marcotulliog, Alain Monnereauh,i,l, the French Network of Cancer Registries (FRANCIM)1, 5 
Bénédicte Clina,b,j, Isabelle Baldii,k,l, Pierre Lebaillya,b,c. 6 
 7 
Author affiliations 8 
a INSERM, UMR 1086 Cancers et Préventions, F-14076, Caen, France. 9 
b Université de Caen Normandie, F-14032, Caen, France. 10 
c Centre de Lutte Contre le Cancer François Baclesse, F-14076, Caen, France. 11 
d Hospices Civils de Lyon, Service de Biostatistique, F-69003, Lyon, France 12 
e Registre des Cancers du Bas-Rhin, Faculté de Médecine, Université de Strasbourg, F-67085, 13 
Strasbourg, France. 14 
f Registre Général des Tumeurs du Calvados, Centre François Baclesse, F-14076, Caen, France. 15 
g Caisse Centrale de la Mutualité Sociale Agricole, Direction de la santé sécurité au travail, F-16 
93547, Bagnolet, France. 17 
h Registre des hémopathies malignes de la Gironde, F-33076, Bordeaux, France 18 
i INSERM, ISPED, Centre INSERM U1219 – Bordeaux Population Health Center, EPICENE 19 
team, F-33076, Bordeaux, France 20 
j CHU de Caen, Service de Pathologie Professionnelle, F-14033, Caen, France. 21 
k Service de Médecine du Travail et Pathologies professionnelles, CHU de Bordeaux, F-33000, 22 
Bordeaux, France. 23 
l Université de Bordeaux, ISPED, Centre INSERM U1219 – Bordeaux Population Health 24 
Center, EPICENE Team, F-33000, Bordeaux, France. 25 
2 
 
1 French Network of Cancer Registries (FRANCIM): Patrick Arveux (Côte d’Or gynecological 26 
tumours CR) ; Valérie Jooste, Anne-Marie Bouvier (Côte d’Or digestive tumours CR) ; Marc 27 
Maynadié, Morgane Mounier (Côte d’Or malignant hemopathies CR) ; Anne-Sophie Woronoff 28 
(Doubs CR); Gaelle Coureau, Sylvain Maurisset (Gironde general CR); Marc Colonna (Isère 29 
CR); Florence Molinié (Loire-Atlantique CR); Simona Bara (Manche CR); Emilie Marrer 30 
(Haut Rhin CR); Bénédicte Lapôtre-Ledoux (Somme CR) ; Pascale Grosclaude, Laetitia 31 
Daubisse-Marliac (Tarn CR) ; Anne Cowppli-Bony (Vendée CR) ; Olivier Dejardin, Véronique 32 
Bouvier, Guy Launoy, Xavier Troussard (Fédération des Registres de Cancers Bas-Normand). 33 
Note: CR= Cancer Registry. 34 
 35 
* corresponding author: C Lemarchand, UMR 1086 Cancers et Préventions, Centre François 36 
Baclesse, Avenue du Général Harris, 14076 Caen Cedex 5 France;  37 
e-mail: c.lemarchand@mail.baclesse.fr 38 
 39 
Word count: 3,690 40 
Tables: 6 41 
Figures: None 42 
Keywords: neoplasms, incidence, cohort studies, agriculture, farmers 43 
 44 
 45 
  46 
3 
 
Abstract: 249 words 47 
 48 
Background: Numerous studies have been conducted among farmers but very few of them 49 
were large prospective cohorts and included a significant proportion of women and 50 
farmworkers. Our aim was to compare cancer incidence in the cohort (overall, by sex, by work 51 
on farm, occupational status and pesticide use) with the general population. 52 
Methods: More than 180,000 participants in the AGRICAN cohort were matched to cancer 53 
registries to identify cancer cases diagnosed from enrolment (2005-2007) to 31st December 54 
2011. We calculated standardized incidence ratios (SIRs) and 95% confidence interval (CI). 55 
Results: Over the period, 11,067 incident cancer cases were identified (7,304 men and 3,763 56 
women). Overall cancer incidence in the cohort and the general population was not different. 57 
Moreover, SIRs were significantly higher for prostate cancer (SIR= 1.07, 95%CI 1.03-1.11) 58 
and non-Hodgkin lymphoma (SIR= 1.09, 95%CI 1.01-1.18) among men, skin melanoma 59 
among women (SIR= 1.23, 95%CI 1.05-1.43) and multiple myeloma (men: SIR= 1.38, 95%CI 60 
1.18-1.62; women: SIR= 1.26, 95%CI 1.02-1.54). In contrast SIRs were lower for upper aero-61 
digestive tract and respiratory cancers. Increase in risk was greater in male farmworkers for 62 
prostate and lip cancer, in female farmworkers for skin melanoma and in male farmowners for 63 
multiple myeloma. Moreover, incidence of multiple myeloma and skin melanoma was higher 64 
among male and female pesticide users respectively.  65 
Conclusion: We found a decreased incidence for tobacco-related cancers and an increased 66 
incidence of prostate cancers, skin melanoma and multiple myeloma. Specific sub-groups had 67 
a higher cancer incidence related to occupational status and pesticide use.   68 
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1. Introduction 69 
 70 
The relationship between farming and cancer has received considerable attention [1,2] and 71 
given rise to general meta-analyses [3,4] and assessment of specific cancers [5-8]. Most studies 72 
found a reduced risk in farmers for cancer overall, especially those related to tobacco smoking, 73 
and an excess risk for some others (lymphohematopoietic, prostate, brain, lip cancers and skin 74 
melanoma), but they were mainly restricted to the male population. Farming entails a large 75 
range of occupational hazards such as ultraviolet radiation, diesel exhaust, viruses, dust and 76 
pesticide use, the latter being the most widely studied regarding cancer risk in the agricultural 77 
context [9,10]. These exposures may differ according to gender, occupational status 78 
(farmowner, farmworker), and farm activities, leading potentially to different health effects. In 79 
some studies, various associations have been reported according to whether farmowners and 80 
farmworkers [11,12] or self-employed, employees and family workers [13] were studied. 81 
Apart from small retrospective studies largely based on mortality data, more recent cohorts have 82 
provided results on cancer incidence among farmers, especially from Nordic countries [14], 83 
with data on type of farm production from farm registries [15] or from a large prospective cohort 84 
study, the Agricultural Health Study (AHS), including pesticide applicators (mainly white male 85 
farmowners) and their spouses [16].  86 
In Europe, the AGRIculture and CANcer (AGRICAN) cohort study assess cancer risk in 87 
agricultural populations in France with detailed individual information on farming activities 88 
and life habits [17]. The analysis of mortality by cancers found overall lower cancer mortality 89 
especially for colon and rectal cancers among males, which was more pronounced for 90 
farmowners than for farmworkers [17]. Almost half of the AGRICAN subjects were women, 91 
so cancer risk could be investigated in this understudied population. Even if pesticide use on 92 
crops was infrequent among AGRICAN women, they used pesticides on animals or on 93 
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embankments and in farmyards. We assessed cancer risk in relation to various profiles (gender, 94 
occupational status, work on farm, pesticide use) in a large cohort of subjects insured by the 95 
farmers’ health insurance scheme and enrolled in AGRICAN. This analysis is an initial part of 96 
the overall project which was and will be completed by further analyses on specific cancer sites, 97 
adjusting on potential confounders, with more detailed information on agricultural activities 98 
and additional duration of follow-up. 99 
 100 
2. Methods 101 
 102 
2.1. Population, Data collection and Enrolment 103 
People involved in agriculture in France have a specific health insurance scheme, the Mutualité 104 
Sociale Agricole (MSA) that includes active and retired people, farmowners and farmworkers 105 
involved in agriculture-related jobs. This insurance agency concerns both people working on a 106 
farm but also beekeepers, foresters, oyster farmers, people working in agricultural cooperatives, 107 
and even tertiary workers serving the agricultural population, defined here as individuals who 108 
never worked on a farm. The AGRICAN cohort is described in detail elsewhere [17]. Briefly, 109 
181,842 subjects were enrolled between 2005 and 2007 with the following criteria: living in 110 
one of the 11 French geographical areas covered by one of the 16 general or specialised 111 
population-based cancer registries at the time of enrolment, being older than 18 years old and 112 
having been insured by the MSA for 3 years or more. A self-administered enrolment 113 
questionnaire was sent to collect individual data on demographic characteristics, lifestyle 114 
habits, health, occupational history and lifetime history (years of beginning and end of activities 115 
and tasks including pesticide use in each crop and animal) of 18 agricultural activities (5 types 116 
of animals and 13 types of crops). Information was also collected on herbicide use on 117 
embankments and/or farmyard. 118 
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 119 
2.2.  Cohort follow-up 120 
Subjects were followed from enrolment (1st November 2005–31st December 2007) to 31st 121 
December 2011. Incident and prevalent cancer cases were identified by cross-linkage with 122 
population-based cancer registries in the 11 geographical areas and were coded according to 123 
the International Classification of Diseases for Oncology, 3rd edition (ICD–O–3). These 124 
registries meet high-quality criteria: the completeness and data quality are regularly assessed 125 
by the Comité National des Registres [French Institute of Health and Medical Research 126 
(INSERM), National Cancer Institute (Inca) and the French Institute for Public Health 127 
Surveillance (InVS)] and data are regularly published by IARC in Cancer Incidence in Five 128 
Continents (CI5). Matching with cancer registries was based on married and maiden names, 129 
first names, gender, date and place of birth, place of residence, vital status and date of death (if 130 
applicable). Only malignant tumours (exclusion of in-situ) were used in this analysis, except 131 
non-melanoma skin cancers due to their non-exhaustive registration. Vital status and place of 132 
residence were checked annually using the MSA data, the French National Postal Service (La 133 
Poste) and the French National Death Index (Répertoire National pour l’Identification des 134 
Personnes Physiques). People moving outside the AGRICAN area (0.8%) were no longer 135 
followed for cancer diagnosis. Person-years accumulation was calculated from the date of 136 
reception of the enrolment questionnaire and ended at cancer diagnosis, date of death (11%), 137 
date of loss to follow-up (less than 2% of subjects) or 31st December 2011, whichever occurred 138 
first. For a given type of cancer, diagnosis between 1st January 2005 (date of implementation 139 
of the most recent registry in the areas concerned) and enrolment were considered as prevalent 140 
and excluded from analysis. Earlier information was not considered because of a major 141 
heterogeneity between registries (implementation of registries extended over 30 years), in order 142 
to avoid selection bias between areas.  143 
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 144 
2.3. Analysis 145 
Standardized incidence ratios (SIRs) were computed to compare the cancer incidence in people 146 
enrolled in the cohort to the total population of the area covered by the study. The expected 147 
numbers of cancer cases were calculated by multiplying the number of person-years in each 5-148 
year age group from 20-24 to ≥85 by the corresponding gender-, age- and geographical area- 149 
specific cancer incidence for the period of observation (2005-2011). 150 
Ninety-five percent confidence intervals (95% CI) for the SIRs were calculated as 151 
recommended by Breslow and Day [18]. Statistical significance was tested by the chi-square 152 
test on the assumption that the number of observed cases followed a Poisson distribution.  153 
Stratified analyses were also conducted by sex, by farm work (ever/never worked on a farm 154 
during lifetime), and among subjects who ever worked on a farm, by occupational status 155 
(farmowner / farmworker) and pesticide use during lifetime (three exclusive categories: (1) at 156 
least pesticide use on crops, (2) use of insecticides on animals or herbicides on embankments 157 
or farmyard but no pesticides on crops and (3) no occupational pesticide use. To assess the 158 
robustness of associations, we performed complementary analyses by censoring cancer cases 159 
at the first date of diagnosis and i) excluding all prevalent cases between 2005 and enrolment 160 
and ii) excluding all prevalent cancers whatever the date of diagnosis. All statistical analyses 161 
were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC). 162 
 163 
3. Results 164 
  165 
General characteristics of the 181,842 subjects who returned the self-administered 166 
questionnaire are presented in Table 1. At enrolment, women (46% of the population) were 167 
older than men (mean age 66.2 and 62.0 respectively). Forty-three percent of men and 58% of 168 
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women had less than middle school education. Men were more often ever-smokers than women 169 
(55% versus 16%), with a greater intensity of cigarette-smoking, more often daily alcohol 170 
consumers (32% versus 8%) and more frequently overweight or obese (64% versus 48%). The 171 
mean duration of affiliation to the health insurance was nearly 24 years. Eighty-seven percent 172 
of men and 86% of women reported having ever worked on farm during lifetime (Table 2). 173 
About 10% of subjects never worked on a farm and a minority had worked in specific 174 
agriculture-related sectors (e.g. agricultural cooperative, fishing, forestry) but not on farm. We 175 
excluded the latter group from the stratified analysis owing to its size and heterogeneity. Among 176 
people who ever worked on farm, men were more often farmowners than women and less often 177 
retired (Supplementary materials 1). Farmworkers were older, more often smokers and had a 178 
lower level of education than farmowners (Supplementary materials 2). Men who ever worked 179 
on farm were more frequently users of pesticides on crops than women (84% versus 34%). 180 
More women than men were only involved in pesticide application in the courtyard or in 181 
animals (26% versus 9%) or used no pesticides (27% versus 7%). Men who ever applied 182 
pesticides more frequently had attained at least middle school, were less often smokers and 183 
were younger than those who never applied pesticides. On the other hand, women applying 184 
pesticides on crops were older than those applying pesticides on the courtyard or on animals 185 
and non-pesticide users (Supplementary materials 2).  186 
 187 
3.1. Overall cancer 188 
During the 5.1 years of follow-up (Supplementary materials 3), there were 7,304 incident cancer 189 
cases among men and 3,763 among women. No difference was observed for overall cancer 190 
incidence for both males (SIR= 0.99, 95%CI 0.97-1.01) and females (SIR= 0.98, 95%CI 0.95-191 
1.02) even if the risk was decreased in farmowners in both genders and was increased in male 192 
farmworkers (SIR= 1.07, 95%CI 1.03-1.12) (Table 3). Cancer incidence was lower among male 193 
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pesticide users on crops (SIR= 0.94, 95%CI 0.91-0.97) and among other pesticide users for both 194 
males (SIR= 0.89, 95%CI 0.81-0.99) and females (SIR= 0.88, 95%CI 0.79-0.99)  195 
 196 
3.2. Upper aero-digestive tract and respiratory cancers 197 
A lower incidence was observed among both men and women for oral cavity and pharynx 198 
cancers (SIR= 0.61, 95%CI 0.53-0.70 and SIR= 0.48, 95%CI 0.33-0.69 respectively), for lung 199 
cancers (SIR= 0.58, 95%CI 0.54-0.63 and SIR= 0.66, 95%CI 0.56-0.77 respectively), and, for 200 
men only, for laryngeal cancers (SIR= 0.56, 95%CI 0.43-0.72) and mesothelioma (SIR= 0.36, 201 
95%CI 0.21-0.56). For most of these cancers, the decrease in risk was more pronounced among 202 
people who ever worked on farm, especially farmowners. No difference was observed 203 
according to pesticide use. 204 
 205 
3.3. Digestive cancers 206 
There was reduction on oesophageal, colon and pancreatic cancers in males, in rectal and anal 207 
cancer in females and in liver cancer in both. Men who ever worked on farm had a lower colon 208 
cancer incidence (SIR= 0.82, 95%CI 0.75-0.90) unlike males who did not work on a farm. 209 
Among women, pancreatic cancer was decreased among farmowners (SIR= 0.67, 95%CI 0.48-210 
0.92) but was greater than one among farmworkers. No overall difference was observed for 211 
stomach cancer even though the risk was decreased in male farmowners (SIR=0.79, 95%CI 212 
0.65-0.96) and was increased in female farmworkers and women who never used pesticides. 213 
 214 
3.4. Reproductive and endocrine system cancers 215 
Men, especially those who ever worked on farm, had a significantly increased incidence of 216 
prostate cancer (SIR= 1.07, 95%CI 1.03-1.12), which was more pronounced among 217 
farmworkers and in subjects who ever (SIR= 1.09, 95%CI 1.03-1.15) or never used pesticides 218 
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(SIR= 1.27, 95%CI 1.06-1.50) (Table 4). The number of male breast cancer cases was higher 219 
than expected. Decreased risks were observed for breast and cervix uteri cancers among all 220 
women and those who ever worked on farm (SIR= 0.84, 95%CI 0.79-0.91 and SIR= 0.64, 221 
95%CI 0.42-0.95 respectively). Breast cancer risk was lower in women who used pesticides on 222 
crops (SIR= 0.70, 95%CI 0.57-0.84). No overall difference was observed for corpus uteri and 223 
ovarian cancers, but there were a higher number of ovarian cancers in pesticide users on crops.  224 
Thyroid cancer was significantly reduced in men who ever worked on farm (SIR= 0.62, 95%CI 225 
0.40-0.93) especially farmowners. No overall difference was observed in women whereas an 226 
increase was observed in female farmowners and those who never used pesticides. 227 
 228 
3.5. Lip and cutaneous cancers 229 
Unlike men, women experienced an increased risk of skin melanoma (SIR= 1.23 95%CI 1.05-230 
1.43), mainly those using pesticides on crops (Table 5). An excess of lip cancer was observed 231 
in men, almost all cases occurring in men using pesticides on crops (SIR= 2.05, 95%CI 1.27-232 
3.13). These excesses were more pronounced among farmworkers.  233 
 234 
3.6. Other solid tumors 235 
Brain cancers, mainly glioblastoma, were increased in men who ever worked on farm and 236 
female pesticide users. The incidence of bladder cancer was lower in men, particularly those 237 
who ever worked on farm (SIR= 0.65, 95%CI 0.57-0.75) similarly among farmowners and 238 
farmworkers. In contrast, the decrease in risk was seen only in female farmworkers (SIR= 0.58, 239 
95%CI 0.35-0.91).  240 
 241 
3.7. Haematological malignancies 242 
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Men had an increased incidence of non-Hodgkin lymphoma (NHL) (SIR= 1.09, 95%CI 1.01-243 
1.18) (Table 6). Higher risks were observed in men and women for multiple myeloma (SIR= 244 
1.38, 95%CI 1.18-1.62 and SIR= 1.26, 95%CI 1.02-1.54 respectively), more pronounced in 245 
male farmowners (SIR=1.59 95%CI 1.29-1.95) and pesticide users on crops (SIR= 1.49, 95%CI 246 
1.19-1.84). The incidence of follicular lymphoma was lower in men (SIR= 0.67, 95%CI 0.45-247 
0.97). In contrast, myelodysplastic syndromes (MDS) were more numerous among women 248 
(SIR= 1.34, 95%CI 1.08-1.63), particularly among farmowners (SIR=1.57 95%CI 1.12-2.13). 249 
 250 
4. Discussion 251 
 252 
This work provides new results on cancer incidence in agricultural population in France. Since 253 
AGRICAN is a large prospective cohort study including farmowners and farmworkers and a 254 
significant proportion of women. Among the 567,157 subjects who met the inclusion criteria, 255 
181,842 returned the self-administered questionnaire and were included in the cohort. Even if 256 
women and younger people participated a little more, geographical distribution was similar 257 
between eligible and enrolled people as well as mean duration of affiliation, for both retired and 258 
active people (Levêque-Morlais, 2015). This large cohort enables the study of rare cancers or 259 
sub-types (for haematological, respiratory or brain cancers) specifically in understudied 260 
populations (i.e. women, farmworkers). Cancer diagnoses were collected exhaustively by 261 
linkage with population based cancer registries and with less than 2% of study subjects lost to 262 
follow-up in the cohort. Individual data on lifetime agricultural exposures were collected before 263 
cancer diagnosis, which limits differential information bias. Pesticide use on crops was less 264 
frequent in women but they also used pesticides on animals or embankments and in farmyard 265 
with a limited number of pesticides (some herbicides and insecticides) and under specific 266 
conditions of exposure (mainly manually). It was therefore possible to study cancer risk in a 267 
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group of non-pesticide users, thereby highlighting other possible occupational risk factors that 268 
seldom received attention.  269 
 270 
There was no difference in the incidence of cancer between cohort members and the general 271 
population. However, the risk in farmowners was decreased for both genders. These findings 272 
are consistent with previous meta-analyses [3,4], a large Nordic cohort study [14] and the AHS 273 
study investigating private pesticide applicators (mainly farmowners) [19,20]. In a 274 
complementary analysis, after excluding all prevalent cancers and when cancer cases were 275 
censored at the first date of diagnosis, a significant lower incidence of overall cancer was 276 
observed. Even if the increase in risk did not persist among the understudied population of 277 
farmworkers, the lower cancer incidence remained more pronounced among farmowners, a 278 
finding that deserves further attention. Significant increased or decreased risks were more 279 
pronounced or similar for individual cancers (Supplementary materials 4). 280 
An increased prostate cancer incidence was previously reported in farmers [3,4,7,14] and 281 
pesticide applicators [19-22]. The increased risk in pesticide users and in non-users suggests 282 
the role of various hazards such as direct or secondary exposure to pesticides applied on crops 283 
and animals and the exposure that grain and hay farmers undergo [23]. 284 
The decreased female breast cancer incidence we found is consistent with results from most 285 
cohort studies [14,24] although no significant difference was observed among private 286 
applicators and spouses in the AHS [20]. One explanation could be a difference in reproductive 287 
characteristics or hormone use, highly related to breast cancer risk. The elevated number of 288 
male breast cancers is in line with elevated mortality we observed previously [17]. This cancer 289 
has only rarely been studied in men and its aetiology remains largely unknown but Pukkala et 290 
al. observed a lower risk among farmers [14].  291 
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To date, thyroid cancer has received little attention among farmers but we observed an increased 292 
risk in women and a decreased risk or no difference in men. A suggestion of a higher incidence 293 
of thyroid cancer was found in the AHS only in commercial applicators [20]. A slight excess 294 
of ovarian cancer in pesticide users was also reported in the AHS in female users but not in 295 
spouses [19,20] or in women exposed to triazines in Italy [25]. 296 
Differences in incidence in farmers might be impacted by screening practices and farmers’ level 297 
of participation. In France, a nationwide screening program was adopted for colorectal cancer 298 
in 2009 and for breast cancer in 2004, and individual screening exists for prostate, thyroid and 299 
cervical cancers. Few data are available and results are not consistent on participation rates of 300 
farmers in collective or individual screening although level of participation seems different 301 
according to health insurance scheme [26]. Preliminary results from a follow-up questionnaire 302 
demonstrated a lower participation rate in prostate cancer screening in AGRICAN than in the 303 
general population, invalidating the hypothesis that screening practices play a major role in our 304 
results.  305 
For lip cancer, an elevated number of cases among farmers was previously observed in meta-306 
analyses [3,4,27], in Nordic countries [14] and to a lesser extent among farmowners using 307 
pesticides in the AHS [19,20]. Solar radiation is the most suggested explanation even if other 308 
etiologic factors are related to lip cancer, such as viruses like herpes simplex virus type 1 (HSV-309 
1), reduced immunity and tobacco-smoking [27,28], especially pipes [29]. 310 
Skin melanoma was also increased in AGRICAN especially among female farmworkers and 311 
pesticide users. Data on skin melanoma in farmers are not consistent. Blair et al. reported a 312 
significant excess of skin melanoma [3] as well as the review from Fortes and de Vries who 313 
observed an association with skin melanoma in both men and women in 9 of the 10 studies 314 
[30], but in contrast with the meta-analysis from Acquavella et al. [4] and the study in Nordic 315 
countries [14]. Finally, in the AHS, no difference was observed among applicators but skin 316 
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melanoma was more frequent in spouses [19,20]. A synergistic effect between occupational 317 
exposure to pesticides and sun exposure has been suggested [31] as well as the fact that chronic 318 
exposure could be a protective factor for skin melanoma [32].  319 
An increase in risk was observed in men for all non-Hodgkin lymphomas. The strongest 320 
association with farming was observed for multiple myeloma in both sexes and it was stronger 321 
in male farmowners and pesticide applicators on crops. Several meta-analyses and a pooled 322 
analysis reported positive associations between multiple myeloma and farming [3,5,33,34] and 323 
among pesticide users in the AHS [19,20]. Furthermore, farmowners involved in open field 324 
activities [35] and pesticide users in the AHS [36] had a greater prevalence of a multiple 325 
myeloma precursor entity, monoclonal gammopathy of undetermined significance (MGUS). In 326 
contrast, our results based on around 30 cases of follicular lymphoma suggested  an unexpected 327 
decreased risk among men while no significant increased risk were observed in InterLymph 328 
[37] or either for private applicators nor spouses in the AHS, even if an increased risk was 329 
reported in North Carolina for private applicators [20]. 330 
The lower incidence of respiratory and bladder cancers can be partly explained by the lower 331 
prevalence of smoking in the present cohort [17] and in the AHS [19] and by exposure to 332 
putative protective factors, as suggested by observations in dairy farming in Italy [38], in 333 
poultry and large-scale livestock farming in the AHS study [39], and in AGRICAN especially 334 
after exposure during childhood and long-term exposure to cattle and horses [40]. 335 
While no overall excess of stomach cancer was observed among men in contrast to the findings 336 
of meta-analyses [3,4], a low increase was observed among women that was greater for 337 
farmworkers and for those who never used pesticides. Likewise, no excess risk was observed 338 
among private applicators in the AHS but a non-significant higher incidence was found for 339 
spouses in North Carolina [20]. The number of brain cancers was elevated in males, especially 340 
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glioblastomas. An excess of brain cancer in farmers was found in a meta-analysis [6] and only 341 
in commercial applicators in the AHS [19,20]. 342 
 343 
This analysis was performed after only 5 years of follow-up but the follow-up will continue to 344 
confirm the results especially for less frequent cancers. Our findings highlight the need to 345 
consider female and farmworkers specifically and they can be used to generate new hypotheses 346 
regarding the role of specific pesticides and other agricultural exposures in cancer aetiology. 347 
Finally, given the range of activities in farming in France and the need to take important 348 
confounding factors into account (e.g. tobacco smoking, alcohol consumption, reproductive 349 
factors), internal analyses on individual cancer sites are underway to identify agricultural 350 
activities and tasks related to cancer risk. 351 
 352 
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Table 1: General characteristics of cohort members, AGRICAN, 2005-2007.  474 
 Men (n= 98794) Women (n= 83048) 
 n % n % 
Age at enrolment (in years)     
20-49 23922 24.2 13942 16.8 
50-64 25560 25.9 18800 22.6 
65-74 23579 23.9 21259 25.6 
75-105 25733 26.0 29047 35.0 
Mean (Std) 62.0 (15.8) 66.2 (15.2) 
     
Highest grade completed     
Less than middle school 40040 43.3 44226 58.1 
Middle school or high school 42165 45.6 25578 33.6 
More than high school 10220 11.1 6346 8.3 
Missing 6369  6898  
     
Smoking status     
Never 41857 44.9 63130 84.5 
Former 38086 40.8 7344 9.8 
Current 13288 14.3 4255 5.7 
Missing 5563  8319  
     
Pack-years of cigarette-smoking     
<20 28100 69.8 8228 86.9 
20-39 9129 22.7 1060 11.2 
40-59 2154 5.3 141 1.5 
≥60 881 2.2 41 0.4 
Missing 1635  472  
Mean (Std) 15.8 (15.5) 9.0 (10.4) 
     
Alcohol consumption     
Never 9067 9.8 24259 33.0 
Monthly 8813 9.5 17630 24.0 
Weekly 45123 48.8 25492 34.6 
Daily 29466 31.9 6191 8.4 
Missing 6325  9476  
     
Body Mass Index (kg/m²)     
Underweight      <18.5 503 0.6 1798 2.7 
Normal weight   18.5-24.9 31138 35.8 33487 49.7 
Overweight        25.0-29.9 41896 48.2 22711 33.7 
Obesity              ≥30.0 13364 15.4 9336 13.9 
Missing 11893  15716  
     
Retired     
No 54235 54.9 37129 44.7 
Yes 44559 45.1 45919 55.3 
     
Duration of affiliation (in years)     
3-9 23205 23.5 18444 22.2 
10-19 18955 19.2 15940 19.2 
20-29 17124 17.3 14440 17.4 
30-39 27540 27.9 21898 26.4 
≥40 11970 12.1 12326 18.8 
Mean (Std) 23.7 (13.7) 24.2 (14.0) 
Abbreviations: Std = Standard deviation.     
475 
22 
 
Table 2: Occupational characteristics of cohort members, AGRICAN, 2005-2007. 476 
 Men (n= 98794) Women (n= 83048) 
 n % n % 
Work on farm     
Ever 76933 87.1 59512 85.9 
Other agricultural activities 2016 2.3 220 0.3 
Never (mainly services sector) 9378 10.6 9520 13.8 
Incomplete job history 10467  13796  
     
Among people who ever worked on farm     
     
     Occupational status     
Farmowners 51351 66.7 31412 52.8 
Farmworkers 25582 33.3 28100 47.2 
     
     Pesticide use     
Pesticides on crops 53435 84.2 10314 34.3 
Herbicides in farmyard 44048 69.4 11038 36.7 
Insecticides on animals 28642 45.1 6913 23.0 
Only herbicides in farmyard or insecticides on animals 5912 9.3 7881 26.2 
No pesticide use 4129 6.5 11851 27.0 
Missing 13454  29466  
 477 
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Table 3: Standardized incidence ratio (SIR) for all sites, upper aero-digestive tract, respiratory and digestive cancers, 2005-2011  479 
 
All 
(n= 98794) 
No work on farm 
(n= 9378) 
Work on farm 
(n= 76933) 
Occupational status Pesticide use 
 
Farmowners (n= 51351) 
Farmworkers  
(n= 25582) 
Pesticides on crops  
(n= 53435) 
Other pesticides  
(n= 4598) 
No pesticides  
(n= 3312) 
 N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] 
Men                 
All sites 7304 0.99 [0.97-1.01] 645 1.02 [0.95-1.10] 5748 0.98 [0.95-1.00] 3619 0.93 [0.90-0.96] 2129 1.07 [1.03-1.12] 3611 0.94 [0.91-0.97] 400 0.89 [0.81-0.99] 362 1.09 [0.98-1.21] 
Upper aero-digestive tract and 
respiratory cancers: 
  
  
            
Oral cavity and pharynx 192 0.61 [0.53-0.70] 22 0.69 [0.43-1.04] 140 0.57 [0.48-0.67] 82 0.48 [0.38-0.60] 58 0.76 [0.58-0.99] 83 0.48 [0.38-0.60] 8 0.42 [0.18-0.83] 7 0.54 [0.22-1.11] 
Larynx 62 0.56 [0.43-0.72] 6 0.57 [0.21-1.24] 40 0.46 [0.33-0.62] 22 0.37 [0.23-0.57] 18 0.63 [0.37-1.00] 21 0.35 [0.22-0.54] 3 0.46 [0.09-1.33] 3 0.63 [0.13-1.85] 
Trachea, bronchus and lung 625 0.58 [0.54-0.63] 74 0.78 [0.61-0.97] 466 0.55 [0.50-0.60] 282 0.50 [0.44-0.56] 184 0.63 [0.55-0.73] 278 0.49 [0.44-0.55] 33 0.51 [0.35-0.72] 26 0.54 [0.35-0.78] 
    Squamous cell 208 0.63 [0.54-0.72] 27 0.94 [0.62-1.37] 155 0.59 [0.50-0.69] 97 0.56 [0.45-0.68] 58 0.64 [0.49-0.83] 95 0.55 [0.45-0.67] 11 0.54 [0.27-0.97] 6 0.40 [0.14-0.86] 
    Adenocarcinoma 192 0.54 [0.47-0.62] 26 0.77 [0.51-1.13] 142 0.51 [0.43-0.60] 84 0.45 [0.36-0.55] 58 0.62 [0.47-0.80] 85 0.45 [0.36-0.55] 11 0.53 [0.26-0.95] 9 0.57 [0.26-1.09] 
Mesothelioma 17 0.36 [0.21-0.58] 1 0.29 [0.00-1.60] 14 0.37 [0.20-0.62] 9 0.36 [0.16-0.69] 5 0.38 [0.12-0.89] 8 0.33 [0.14-0.65] 2 0.72 [0.08-2.61] 1 0.49 [0.01-2.72] 
Digestive organs:   
  
            
Oesophagus 150 0.78 [0.66-0.92] 12 0.73 [0.38-1.27] 113 0.74 [0.61-0.89] 72 0.70 [0.55-0.88] 41 0.82 [0.59-1.11] 58 0.57 [0.44-0.74] 8 0.69 [0.30-1.35] 10 1.23 [0.59-2.26] 
Stomach 217 0.90 [0.78-1.02] 10 0.56 [0.27-1.04] 169 0.87 [0.74-1.01] 102 0.79 [0.65-0.96] 67 1.00 [0.78-1.27] 114 0.93 [0.77-1.12] 8 0.53 [0.23-1.05] 9 0.81 [0.37-1.54] 
Colon 609 0.87 [0.80-0.94] 66 1.25 [0.96-1.59] 465 0.82 [0.75-0.90] 275 0.75 [0.67-0.85] 190 0.95 [0.82-1.09] 299 0.82 [0.73-0.92] 31 0.76 [0.52-1.08] 26 0.82 [0.53-1.20] 
Rectum 396 0.99 [0.89-1.09] 27 0.84 [0.55-1.22] 317 0.98 [0.88-1.10] 212 1.00 [0.87-1.14] 105 0.95 [0.78-1.15] 188 0.90 [0.78-1.04] 26 1.07 [0.70-1.57] 15 0.83 [0.47-1.37] 
Liver and intrahepatic bile ducts 257 0.80 [0.70-0.90] 21 0.76 [0.47-1.16] 197 0.77 [0.66-0.88] 138 0.82 [0.69-0.97] 59 0.67 [0.51-0.86] 120 0.70 [0.58-0.84] 17 0.92 [0.53-1.47] 8 0.58 [0.25-1.15] 
Pancreas 179 0.81 [0.70-0.94] 14 0.77 [0.42-1.30] 145 0.82 [0.69-0.97] 97 0.85 [0.69-1.03] 48 0.78 [0.57-1.03] 89 0.77 [0.62-0.95] 11 0.85 [0.42-1.52] 10 1.01 [0.49-1.87] 
Anus 6 0.47 [0.17-1.03] 1 0.92 [0.01-5.11] 4 0.40 [0.11-1.01] 2 0.31 [0.03-1.11] 2 0.56 [0.06-2.03] 3 0.45 [0.09-1.31] 1 1.37 [0.02-7.62] 0 - 
                 
Women                 
All sites 3763 0.98 [0.95-1.02] 342 1.08 [0.97-1.20] 2708 0.95 [0.91-0.98] 1346 0.93 [0.88-0.98] 1362 0.97 [0.92-1.02] 474 0.97 [0.88-1.06] 303 0.88 [0.79-0.99] 533 1.01 [0.92-1.09] 
Upper aero-digestive tract and 
respiratory cancers: 
                
Oral cavity and pharynx 30 0.48 [0.33-0.69] 4 0.65 [0.17-1.66] 20 0.44 [0.27-0.68] 9 0.37 [0.17-0.70] 11 0.53 [0.26-0.94] 1 0.13 [0.00-0.71] 1 0.17 [0.00-0.96] 5 0.57 [0.18-1.32] 
Larynx 7 0.78 [0.31-1.61] 0 - 7 1.06 [0.43-2.19] 3 0.82 [0.16-2.40] 4 1.37 [0.37-3.51] 0 - 0 - 1 0.78 [0.01-4.36] 
Trachea, bronchus and lung 150 0.66 [0.56-0.77] 15 0.73 [0.41-1.20] 100 0.59 [0.48-0.72] 47 0.54 [0.40-0.72] 53 0.64 [0.48-0.83] 16 0.54 [0.31-0.88] 14 0.69 [0.38-1.15] 18 0.56 [0.33-0.88] 
    Squamous cell 17 0.54 [0.31-0.86] 2 0.75 [0.08-2.70] 9 0.38 [0.17-0.72] 6 0.50 [0.18-1.09] 3 0.26 [0.05-0.75] 1 0.25 [0.00-1.36] 3 1.06 [0.21-3.10] 1 0.23 [0.00-1.27] 
    Adenocarcinoma 96 0.82 [0.66-1.00] 10 0.91 [0.43-1.67] 65 0.75 [0.58-0.96] 32 0.72 [0.49-1.01] 33 0.79 [0.54-1.11] 13 0.87 [0.46-1.49] 7 0.67 [0.27-1.38] 12 0.73 [0.37-1.27] 
Mesothelioma 7 0.74 [0.30-1.52] 1 1.65 [0.02-9.20] 6 0.83 [0.30-1.81] 3 0.83 [0.17-2.42] 3 0.84 [0.14-2.45] 3 2.60 [0.52-7.59] 1 1.24 [0.02-6.91] 0 - 
Digestive organs: 
                
Oesophagus 24 0.73 [0.47-1.08] 2 0.85 [0.10-3.06] 17 0.68 [0.40-1.10] 6 0.50 [0.18-1.10] 11 0.85 [0.42-1.52] 3 0.73 [0.15-2.15] 1 0.34 [0.00-1.89] 5 1.11 [0.36-2.60] 
Stomach 100 1.05 [0.85-1.28] 6 1.13 [0.41-2.46] 82 1.12 [0.89-1.39] 35 1.02 [0.71-1.42] 47 1.21 [0.89-1.61] 11 0.91 [0.45-1.62] 7 0.83 [0.33-1.72] 17 1.32 [0.77-2.11] 
Colon 424 0.95 [0.86-1.05] 23 0.87 [0.55-1.31] 319 0.94 [0.84-1.05] 153 1.01 [0.85-1.18] 166 0.89 [0.76-1.03] 60 1.04 [0.80-1.34] 31 0.83 [0.56-1.17] 55 0.91 [0.69-1.19] 
Rectum 162 0.84 [0.72-0.98] 14 1.08 [0.59-1.81] 122 0.84 [0.69-1.00] 55 0.79 [0.60-1.03] 67 0.88 [0.68-1.11] 19 0.78 [0.47-1.22] 21 1.24 [0.77-1.90] 15 0.58 [0.32-0.95] 
Liver and intrahepatic bile ducts 43 0.71 [0.51-0.95] 4 1.04 [0.28-2.66] 32 0.70 [0.48-0.98] 14 0.69 [0.38-1.16] 18 0.70 [0.41-1.11] 9 1.16 [0.53-2.20] 4 0.79 [0.21-2.02] 6 0.73 [0.27-1.59] 
Pancreas 157 0.93 [0.79-1.09] 13 1.27 [0.67-2.16] 118 0.92 [0.76-1.10] 38 0.67 [0.48-0.92] 80 1.12 [0.89-1.39] 22 1.01 [0.63-1.53] 9 0.63 [0.29-1.19] 21 0.91 [0.57-1.40] 
Anus 14 0.55 [0.30-0.93] 2 0.90 [0.10-3.26] 8 0.42 [0.18-0.84] 6 0.61 [0.22-1.34] 2 0.22 [0.02-0.80] 2 0.63 [0.07-2.28] 1 0.43 [0.01-2.42] 1 0.28 [0.00-1.57] 
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Table 4: Standardized incidence ratio (SIR) for reproductive and endocrine system cancers, 2005-2011 482 
 
All 
(n= 98794) 
No work on farm 
(n= 9378) 
Work on farm 
(n= 76933) 
Occupational status Pesticide use 
 
Farmowners (n= 51351) 
Farmworkers  
(n= 25582) 
Pesticides on crops  
(n= 53435) 
Other pesticides  
(n= 4598) 
No pesticides  
(n= 3312) 
 N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] 
Men                 
Breast 20 1.02 [0.62-1.58] 1 0.60 [0.01-3.33] 19 1.22 [0.73-1.90] 12 1.18 [0.61-2.05] 7 1.30 [0.52-2.68] 11 1.07 [0.53-1.92] 2 1.75 [0.20-6.31] 0 - 
Prostate 2538 1.07 [1.03-1.11] 207 0.97 [0.84-1.11] 2032 1.07 [1.03-1.12] 1286 1.02 [0.97-1.08] 746 1.17 [1.09-1.26] 1345 1.09 [1.03-1.15] 125 0.85 [0.71-1.02] 136 1.27 [1.06-1.50] 
Testis 16 0.78 [0.44-1.26] 5 2.25 [0.72-5.24] 10 0.65 [0.31-1.20] 6 0.59 [0.22-1.28] 4 0.77 [0.21-1.98] 8 0.69 [0.30-1.35] 0 - 0 - 
Thyroid 39 0.79 [0.56-1.07] 6 1.14 [0.41-2.47] 24 0.62 [0.40-0.93] 15 0.58 [0.32-0.96] 9 0.71 [0.32-1.35] 19 0.69 [0.41-1.07] 1 0.36 [0.00-2.00] 2 0.96 [0.11-3.45] 
                 
Women                 
Breast 1086 0.89 [0.84-0.95] 139 1.08 [0.91-1.28] 749 0.84 [0.79-0.91] 426 0.88 [0.80-0.97] 323 0.80 [0.72-0.89] 105 0.70 [0.57-0.84] 94 0.82 [0.66-1.00] 181 1.05 [0.91-1.22] 
Cervix uteri 38 0.70 [0.50-0.96] 3 0.49 [0.10-1.42] 25 0.64 [0.42-0.95] 11 0.53 [0.27-0.96] 14 0.77 [0.42-1.29] 5 0.72 [0.23-1.69] 2 0.39 [0.04-1.40] 6 0.78 [0.29-1.70] 
Corpus uteri 213 1.03 [0.90-1.18] 18 1.05 [0.62-1.66] 159 1.03 [0.87-1.20] 78 0.97 [0.77-1.21] 81 1.08 [0.86-1.34] 27 1.02 [0.67-1.49] 16 0.87 [0.50-1.41] 32 1.12 [0.77-1.59] 
Ovary 145 1.06 [0.89-1.24] 15 1.33 [0.74-2.19] 103 1.00 [0.81-1.21] 52 0.94 [0.70-1.23] 51 1.06 [0.79-1.40] 22 1.28 [0.80-1.93] 10 0.79 [0.38-1.45] 19 1.01 [0.61-1.57] 
Thyroid 101 1.05 [0.86-1.28] 16 1.11 [0.63-1.79] 69 1.04 [0.81-1.32] 47 1.21 [0.89-1.61] 22 0.80 [0.50-1.21] 12 1.04 [0.54-1.82] 11 1.22 [0.61-2.18] 21 1.44 [0.89-2.20] 
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Table 5: Standardized incidence ratio (SIR) for lip, cutaneous cancers and other solid tumors, 2005-2011 485 
 
All 
(n= 98794) 
No work on farm 
(n= 9378) 
Work on farm 
(n= 76933) 
Occupational status Pesticide use 
 
Farmowners (n= 51351) 
Farmworkers  
(n= 25582) 
Pesticides on crops  
(n= 53435) 
Other pesticides  
(n= 4598) 
No pesticides  
(n= 3312) 
 N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] 
Men                 
Lip and cutaneous cancers:                 
Lip 27 1.38 [0.91-2.01] 0 - 27 1.69 [1.11-2.45] 12 1.11 [0.57-1.94] 15 2.87 [1.61-4.74] 21 2.05 [1.27-3.13] 1 0.83 [0.01-4.60] 0 - 
Skin melanoma 178 0.96 [0.83-1.12] 17 1.05 [0.61-1.69] 137 0.94 [0.79-1.11] 75 0.78 [0.61-0.98] 62 1.24 [0.95-1.59] 96 0.98 [0.80-1.20] 12 1.14 [0.59-2.00] 6 0.74 [0.27-1.62] 
Other solid tumours:                 
Central nervous system 87 0.96 [0.77-1.18] 3 0.37 [0.08-1.09] 76 1.06 [0.83-1.32] 56 1.17 [0.88-1.52] 20 0.83 [0.51-1.28] 52 1.09 [0.81-1.43] 5 0.90 [0.29-2.11] 2 0.50 [0.06-1.79] 
    Gliomas 81 1.00 [0.79-1.24] 3 0.40 [0.08-1.18] 70 1.09 [0.85-1.38] 50 1.16 [0.86-1.53] 20 0.94 [0.57-1.45] 48 1.12 [0.83-1.48] 5 1.00 [0.32-2.33] 2 0.55 [0.06-1.98] 
        Glioblastomas 56 1.04 [0.78-1.35] 3 0.60 [0.12-1.76] 48 1.12 [0.83-1.49] 36 1.26 [0.88-1.74] 12 0.85 [0.44-1.48] 32 1.12 [0.77-1.59] 3 0.91 [0.18-2.66] 2 0.81 [0.09-2.93] 
Bladder 278 0.67 [0.60-0.76] 32 1.04 [0.71-1.47] 217 0.65 [0.57-0.75] 133 0.62 [0.52-0.74] 84 0.70 [0.56-0.87] 124 0.59 [0.49-0.70] 14 0.58 [0.31-0.97] 18 0.93 [0.55-1.47] 
Kidney 301 0.99 [0.88-1.11] 27 1.05 [0.69-1.52] 236 0.97 [0.85-1.10] 157 0.99 [0.84-1.15] 79 0.94 [0.75-1.18] 151 0.94 [0.80-1.11] 16 0.91 [0.52-1.47] 17 1.23 [0.71-1.97] 
                 
Women                 
Lip and cutaneous cancers:                 
Lip 4 0.75 [0.20-1.92] 0 - 1 0.24 [0.00-1.35] 1 0.58 [0.01-3.20] 0 - 0 - 1 2.24 [0.03-12.45] 0 - 
Skin melanoma 169 1.23 [1.05-1.43] 18 1.36 [0.80-2.14] 123 1.21 [1.01-1.45] 61 1.14 [0.87-1.46] 62 1.30 [1.00-1.66] 26 1.50 [0.98-2.19] 10 0.80 [0.38-1.48] 18 0.93 [0.55-1.46] 
Other solid tumours:                 
Central nervous system 52 0.96 [0.72-1.26] 3 0.66 [0.13-1.92] 40 0.99 [0.71-1.35] 16 0.80 [0.46-1.30] 24 1.18 [0.76-1.76] 10 1.45 [0.69-2.66] 8 1.68 [0.72-3.31] 5 0.67 [0.22-1.56] 
    Gliomas 43 0.94 [0.68-1.26] 3 0.72 [0.15-2.12] 31 0.91 [0.62-1.29] 14 0.78 [0.43-1.32] 17 1.04 [0.61-1.67] 8 1.37 [0.59-2.71] 5 1.22 [0.39-2.85] 4 0.63 [0.17-1.62] 
        Glioblastomas 26 0.88 [0.58-1.29] 2 0.78 [0.09-2.80] 20 0.91 [0.55-1.40] 9 0.76 [0.35-1.45] 11 1.07 [0.54-1.92] 5 1.32 [0.42-3.07] 4 1.56 [0.42-3.99] 2 0.49 [0.05-1.77] 
Bladder 60 0.79 [0.61-1.02] 2 0.51 [0.06-1.82] 43 0.74 [0.54-1.00] 24 0.95 [0.61-1.42] 19 0.58 [0.35-0.91] 10 1.00 [0.48-1.83] 5 0.79 [0.26-1.85] 5 0.49 [0.16-1.13] 
Kidney 118 0.99 [0.82-1.18] 8 0.92 [0.39-1.81] 86 0.95 [0.76-1.18] 46 1.02 [0.74-1.36] 40 0.89 [0.64-1.21] 18 1.16 [0.68-1.83] 7 0.68 [0.27-1.39] 13 0.80 [0.42-1.37] 
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Table 6: Standardized incidence ratio (SIR) for haematological malignancies, 2005-2011 488 
 
All 
(n= 98794) 
No work on farm 
(n= 9378) 
Work on farm 
(n= 76933) 
Occupational status Pesticide use 
 
Farmowners (n= 51351) 
Farmworkers  
(n= 25582) 
Pesticides on crops  
(n= 53435) 
Other pesticides  
(n= 4598) 
No pesticides  
(n= 3312) 
 N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] N obs SIR [95%CI] 
Men                 
Hodgkin Lymphoma 24 1.28 [0.82-1.90] 2 1.18 [0.13-4.27] 19 1.29 [0.78-2.02] 10 1.04 [0.50-1.92] 9 1.75 [0.80-3.33] 10 0.97 [0.46-1.78] 2 1.88 [0.21-6.79] 3 3.81 [0.77-11.14] 
Non Hodgkin Lymphoma 644 1.09 [1.01-1.18] 57 1.23 [0.93-1.59] 516 1.09 [1.00-1.19] 336 1.10 [0.98-1.22] 180 1.08 [0.92-1.25] 310 1.01 [0.90-1.12] 40 1.16 [0.83-1.58] 32 1.23 [0.84-1.73] 
    Chronic lymphocytic leukaemia/lymphocytic 
lymphoma 
151 1.09 [0.93-1.28] 13 1.21 [0.64-2.07] 124 1.12 [0.93-1.33] 80 1.11 [0.88-1.38] 44 1.12 [0.82-1.51] 69 0.97 [0.75-1.22] 12 1.45 [0.75-2.53] 7 1.12 [0.45-2.30] 
    Follicular lymphoma 29 0.67 [0.45-0.97] 4 1.00 [0.27-2.56] 22 0.65 [0.40-0.98] 17 0.75 [0.44-1.20] 5 0.44 [0.14-1.03] 13 0.56 [0.30-0.95] 2 0.82 [0.09-2.97] 2 1.11 [0.12-3.99] 
    Malignant lymphoma, large B-cell, diffuse 116 1.12 [0.93-1.34] 8 1.02 [0.44-2.01] 92 1.10 [0.89-1.35] 57 1.06 [0.80-1.37] 35 1.19 [0.83-1.65] 50 0.93 [0.69-1.23] 6 0.98 [0.36-2.14] 8 1.74 [0.75-3.42] 
    Mantle cell lymphoma 21 0.96 [0.59-1.47] 2 1.12 [0.13-4.05] 13 0.74 [0.39-1.27] 9 0.80 [0.36-1.52] 4 0.64 [0.17-1.63] 7 0.62 [0.25-1.27] 3 2.31 [0.46-6.75] 1 1.00 [0.01-5.54] 
    Marginal zone lymphoma 35 1.02 [0.71-1.42] 1 0.36 [0.00-2.00] 27 0.98 [0.65-1.43] 15 0.86 [0.48-1.41] 12 1.21 [0.62-2.11] 16 0.90 [0.51-1.46] 2 0.97 [0.11-3.51] 2 1.29 [0.14-4.65] 
    Multiple myeloma and plasmocytoma 157 1.38 [1.18-1.62] 13 1.49 [0.79-2.54] 129 1.42 [1.18-1.68] 93 1.59 [1.29-1.95] 36 1.10 [0.77-1.52] 88 1.49 [1.19-1.84] 8 1.23 [0.53-2.42] 5 0.98 [0.32-2.29] 
    Lymphoplasmacytic lymphoma/Waldentröm  49 1.03 [0.77-1.37] 4 1.15 [0.31-2.93] 44 1.15 [0.83-1.54] 29 1.16 [0.78-1.66] 15 1.12 [0.63-1.86] 28 1.12 [0.75-1.62] 3 1.10 [0.22-3.22] 2 1.00 [0.11-3.61] 
    NK/T-cell lymphoma  40 1.16 [0.83-1.58] 5 1.71 [0.55-3.99] 28 1.02 [0.68-1.48] 14 0.79 [0.43-1.33] 14 1.45 [0.79-2.43] 17 0.94 [0.55-1.50] 2 1.02 [0.11-3.68] 2 1.32 [0.15-4.77] 
        Mycosis fungoides 11 0.99 [0.49-1.77] 2 2.03 [0.23-7.34] 8 0.91 [0.39-1.80] 3 - 5 1.56 [0.50-3.65] 5 0.85 [0.28-1.99] 0 - 1 1.95 [0.03-10.84] 
    Non Hodgkin Lymphoma NOS 29 0.87 [0.58-1.25] 4 1.78 [0.48-4.55] 24 0.89 [0.57-1.32] 14 0.81 [0.44-1.36] 10 1.02 [0.49-1.87] 13 0.73 [0.39-1.26] 1 0.57 [0.01-3.15] 2 1.43 [0.16-5.17] 
Acute myeloid leukaemia 64 1.00 [0.77-1.28] 8 1.68 [0.72-3.31] 50 0.97 [0.72-1.28] 29 0.88 [0.59-1.27] 21 1.12 [0.69-1.72] 25 0.76 [0.49-1.12] 4 1.09 [0.29-2.79] 4 1.38 [0.37-3.53] 
Chronic myeloproliferative disorders 72 0.86 [0.67-1.08] 5 0.74 [0.24-1.73] 62 0.93 [0.71-1.19] 31 0.71 [0.48-1.01] 31 1.32 [0.89-1.87] 29 0.66 [0.44-0.95] 10 2.01 [0.96-3.69] 6 1.61 [0.59-3.50] 
Myelodysplastic syndrome 122 0.93 [0.77-1.11] 6 0.73 [0.27-1.59] 96 0.90 [0.73-1.10] 67 0.99 [0.77-1.26] 29 0.74 [0.50-1.07] 59 0.91 [0.69-1.18] 5 0.63 [0.20-1.48] 7 1.10 [0.44-2.27] 
Cutaneous lymphoma 25 1.02 [0.66-1.50] 2 0.97 [0.11-3.49] 19 0.97 [0.59-1.52] 11 0.87 [0.43-1.56] 8 1.16 [0.50-2.29] 11 0.84 [0.42-1.51] 4 2.95 [0.79-7.56] 1 0.94 [0.01-5.23] 
                 
Women                 
Hodgkin Lymphoma 10 1.10 [0.52-2.01] 2 1.84 [0.21-6.65] 6 0.93 [0.34-2.02] 4 1.20 [0.32-3.07] 2 0.64 [0.07-2.32] 2 1.75 [0.20-6.32] 1 1.18 [0.02-6.55] 0 - 
Non Hodgkin Lymphoma 367 1.05 [0.94-1.16] 29 1.21 [0.81-1.74] 262 0.99 [0.87-1.11] 110 0.89 [0.73-1.08] 152 1.07 [0.91-1.25] 48 1.10 [0.81-1.45] 32 1.05 [0.72-1.49] 56 1.18 [0.89-1.54] 
    Chronic lymphocytic leukaemia/lymphocytic 
lymphoma 
67 0.94 [0.73-1.19] 5 1.06 [0.34-2.48] 51 0.94 [0.70-1.23] 22 0.86 [0.54-1.30] 29 1.01 [0.67-1.45] 13 1.48 [0.79-2.53] 5 0.80 [0.26-1.86] 9 0.93 [0.43-1.77] 
    Follicular lymphoma 33 1.02 [0.70-1.43] 2 0.68 [0.08-2.44] 25 1.04 [0.67-1.53] 12 0.92 [0.47-1.60] 13 1.18 [0.63-2.01] 7 1.76 [0.70-3.62] 4 1.36 [0.36-3.47] 4 0.89 [0.24-2.27] 
    Malignant lymphoma, large B-cell, diffuse 70 0.97 [0.75-1.22] 6 1.32 [0.48-2.88] 43 0.78 [0.57-1.05] 17 0.69 [0.40-1.10] 26 0.86 [0.56-1.26] 7 0.76 [0.31-1.58] 4 0.65 [0.17-1.65] 12 1.23 [0.64-2.15] 
    Mantle cell lymphoma 7 1.10 [0.44-2.27] 0 - 6 1.24 [0.45-2.71] 2 0.81 [0.09-2.93] 4 1.69 [0.46-4.34] 1 1.28 [0.02-7.12] 1 1.70 [0.02-9.47] 1 1.18 [0.02-6.57] 
    Marginal zone lymphoma 27 1.10 [0.73-1.60] 1 0.56 [0.01-3.09] 22 1.19 [0.75-1.80] 7 0.80 [0.32-1.64] 15 1.55 [0.87-2.55] 5 1.65 [0.53-3.86] 4 1.87 [0.50-4.79] 5 1.49 [0.48-3.48] 
    Multiple myeloma and plasmocytoma 97 1.26 [1.02-1.54] 9 1.79 [0.82-3.41] 75 1.29 [1.01-1.61] 35 1.33 [0.92-1.85] 40 1.25 [0.89-1.70] 11 1.12 [0.56-2.01] 8 1.21 [0.52-2.39] 15 1.46 [0.81-2.40] 
    Lymphoplasmacytic lymphoma/Waldentröm 24 1.18 [0.76-1.76] 0 - 16 1.03 [0.59-1.67] 6 0.89 [0.32-1.93] 10 1.14 [0.54-2.09] 2 0.79 [0.09-2.87] 2 1.18 [0.13-4.24] 3 1.12 [0.22-3.27] 
    NK/T-cell lymphoma  24 1.40 [0.90-2.08] 6 4.45 [1.63-9.69] 13 1.01 [0.54-1.72] 7 1.11 [0.44-2.28] 6 0.91 [0.33-1.99] 0 - 2 1.33 [0.15-4.79] 4 1.72 [0.46-4.40] 
        Mycosis fungoides 2 0.51 [0.06-1.84] 1 2.45 [0.03-13.61] 0 - 0 - 0 - 0 - 0 - 0 - 
    Non Hodgkin Lymphoma NOS 14 0.66 [0.36-1.11] 0 - 8 0.49 [0.21-0.97] 1 0.16 [0.00-0.87] 7 0.71 [0.28-1.47] 1 0.37 [0.00-2.06] 0 - 3 1.04 [0.21-3.04] 
Acute myeloid leukaemia 40 1.05 [0.75-1.43] 3 1.10 [0.22-3.23] 26 0.91 [0.59-1.33] 8 0.60 [0.26-1.17] 18 1.18 [0.70-1.86] 7 1.43 [0.57-2.95] 3 0.91 [0.18-2.66] 6 1.15 [0.42-2.49] 
Chronic myeloproliferative disorders 58 1.08 [0.82-1.40] 8 2.07 [0.89-4.09] 40 0.99 [0.71-1.35] 27 1.38 [0.91-2.00] 13 0.63 [0.33-1.07] 5 0.74 [0.24-1.72] 4 0.83 [0.22-2.14] 11 1.51 [0.75-2.71] 
Myelodysplastic syndrome 97 1.34 [1.08-1.63] 5 1.47 [0.47-3.43] 78 1.40 [1.10-1.74] 40 1.57 [1.12-2.13] 38 1.25 [0.89-1.72] 14 1.45 [0.79-2.44] 9 1.48 [0.67-2.80] 12 1.22 [0.63-2.13] 
Cutaneous lymphoma 14 1.04 [0.57-1.75] 4 3.79 [1.02-9.70] 7 0.69 [0.28-1.43] 2 0.43 [0.05-1.54] 5 0.92 [0.30-2.16] 1 0.59 [0.01-3.28] 2 1.76 [0.20-6.36] 0 - 
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